<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No.:
Name of Issuer: Neopharm, Inc.
Title of Class of Securities: Common Stock, $.0002145 par value
CUSIP Number: 640919106
(Date of Event Which Requires Filing of this Statement)
December 22, 1997
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP Number: 640919106
1. Name of Reporting Person
I.R.S. Identification No. of Above Person
John P. Curran
2. Check the Appropriate Box if a Member of a Group
a.
b.
3. SEC Use Only
4. Citizenship or Place of Organization
United States
Number of Shares Beneficially Owned by Each Reporting Person
With:
5. Sole Voting Power:
94,600
6. Shared Voting Power:
428,400 (including Warrants exercisable for
104,000 shares of Common Stock)
7. Sole Dispositive Power:
94,600
8. Shared Dispositive Power:
428,400 (including Warrants exercisable for
104,000 shares of Common Stock)
9. Aggregate Amount Beneficially Owned by Each Reporting Person
523,000
10. Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares
-2-
<PAGE>
11. Percent of Class Represented by Amount in Row (9)
6.30%
12. Type of Reporting Person
IN
-3-
<PAGE>
CUSIP Number: 640919106
1. Name of Reporting Person
I.R.S. Identification No. of Above Person
Curran Partners, L.P.
2. Check the Appropriate Box if a Member of a Group
a.
b.
3. SEC Use Only
4. Citizenship or Place of Organization
Delaware
Number of Shares Beneficially Owned by Each Reporting Person
With:
5. Sole Voting Power:
6. Shared Voting Power:
428,400 (including Warrants exercisable for
104,000 shares of Common Stock)
7. Sole Dispositive Power:
8. Shared Dispositive Power:
428,400 (including Warrants exercisable for
104,000 shares of Common Stock)
9. Aggregate Amount Beneficially Owned by Each Reporting
Person
428,400 (including Warrants exercisable for
104,000 shares of Common Stock)
10. Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares
-4-
<PAGE>
11. Percent of Class Represented by Amount in Row (9)
5.16%
12. Type of Reporting Person
PN
-5-
<PAGE>
Item 1(a) Name of Issuer: Neopharm, Inc.
(b) Address of Issuer's Principal Executive Offices:
100 Corporate North
Suite 215
Bannockburn, IL 60015
Item 2(a) - (c). Name, Principal Business Address, and
Citizenship of Persons Filing:
The principal address of John P. Curran and Curran
Partners, L.P. (the "Partnership") is 230 Park
Avenue, New York, New York 10169.
John P. Curran is a United States citizen. The
Partnership is a Delaware limited partnership.
(d) Title of Class of Securities: Common Stock,
$.0002145 par value (the "Common Stock")
(e) CUSIP Number: 640919106
Item 3. If this statement is filed pursuant to Rule
13d-1(b)(1) or 13d-2(b) or (c) check whether the person
filing is:
(a) / / Broker or dealer registered under Section 15 of
the Act,
(b) / / Bank as defined in Section 3(a)(6) of the Act,
(c) / / Insurance Company as defined in
Section 3(a)(19) of the Act,
(d) / / Investment Company registered under Section 8
of the Investment Company Act,
(e) / / Investment Adviser registered under Section 203
of the Investment Advisers Act of 1940,
(f) / / Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee
Retirement Income Security Act of 1974 or
Endowment Fund,
(g) / / Parent Holding Company, in accordance with Rule
13d-1(b)(ii)(G),
-6-
<PAGE>
(h) / / Savings association as defined in Section 3(b)
of the Federal Deposit Insurance Act,
(i) / / Church plan excluded from the definition of an
investment company under Section 3(c)(14) of
the Investment Company Act,
(j) / / Group, in accordance with Rule 13d-
1(b)(1)(ii)(H).
If this statement is filed pursuant to Rule 13d-1(c), check
this box. /X/
Item 4. Ownership.
(a) Amount Beneficially Owned: Mr. Curran owns
523,000 shares of Common Stock (including
Warrants exercisable for 104,000 shares of
Common Stock); the Partnership owns 428,400
shares of Common Stock (including Warrants
exercisable for 104,000 shares of Common
Stock).
(b) Percent of Class: Mr. Curran's shares
represent 6.30% of the outstanding Common
Stock; the Partnership's shares represent 5.16%
of the outstanding Common Stock.
(c) Mr. Curran: 94,600 shares with sole power
to vote or to direct the vote; 428,400 shares
with shared power to vote or to direct the
vote; 94,600 shares with sole power to dispose
or of which to direct the disposition; 428,400
shares with shared power to dispose or of which
to direct the disposition. The Partnership: 0
shares with sole power to vote or to direct the
vote; 428,400 shares with shared power to vote
or to direct the vote; 0 shares with sole power
to dispose or of which to direct the
disposition; 428,400 shares with shared power
to dispose or of which to direct the
disposition.
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
-7-
<PAGE>
Item 6. Ownership of More than Five Percent on Behalf of
Another Person.
Not Applicable
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of the
Group.
Not Applicable
Item 9. Notice of Dissolution of the Group.
Not Applicable
Item 10.
Certification for Rule 13d-1(c): By signing below I
certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and
were not acquired and are not held in connection with or as
a participant in any transaction having that purpose or
effect.
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set
forth in this statement is true, complete and correct.
/s/ John P. Curran June 16, 1998
______________________ ___________________
JOHN P. CURRAN Date
CURRAN PARTNERS, L.P.
By: /s/ John P. Curran June 16, 1998
_________________________ ___________________
Title: General Partner Date
-8-
1616000.AF9
